Cost-utility analysis of nanoparticle albumin-bound paclitaxel (nab-paclitaxel) in combination with gemcitabine in metastatic pancreatic cancer in Spain: results of the PANCOSTABRAX study-Reference-Cited by-同舟云学术

Cost-utility analysis of nanoparticle albumin-bound paclitaxel (nab-paclitaxel) in combination with gemcitabine in metastatic pancreatic cancer in Spain: results of the PANCOSTABRAX study

Published:2015-05-19 Issue:4 Volume:15 Page:579-589
ISSN:1473-7167
Container-title:Expert Review of Pharmacoeconomics & Outcomes Research
language:en
Short-container-title:Expert Review of Pharmacoeconomics & Outcomes Research

Author:

Carrato Alfredo,García Pilar,López Rafael,Macarulla Teresa,Rivera Fernando,Sastre Javier,Gostkorzewicz Joana,Benedit Patricia,Pérez-Alcántara Ferran

Publisher

Informa UK Limited

Subject

Pharmacology (medical),Health Policy,General Medicine

Link

http://www.tandfonline.com/doi/pdf/10.1586/14737167.2015.1047349

Reference29 articles.

1. Pancreatic Cancer Surgery in the New Millennium

2. Conditional survival in patients with pancreatic ductal adenocarcinoma resected with curative intent

3. A Randomized Trial of Chemoradiotherapy and Chemotherapy after Resection of Pancreatic Cancer

4. Pancreatic cancer

5. TTD consensus document on the diagnosis and management of exocrine pancreatic cancer

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. On cost-effectiveness analysis, quality-adjusted life years, and cost-effectiveness threshold values of gemcitabine plus nab-paclitaxel versus gemcitabine alone in metastatic pancreatic cancer in the French setting;Therapeutic Advances in Medical Oncology;2024-01

2. French multi-institutional cost-effectiveness analysis of gemcitabine plus nab-paclitaxel versus gemcitabine alone as second-line treatment in metastatic pancreatic cancer patients;Therapeutic Advances in Medical Oncology;2024-01

3. Economic Burden of Pancreatic Cancer in Europe: a Literature Review;Journal of Gastrointestinal Cancer;2022-04-26

4. Cost-Effectiveness of Nab-Paclitaxel and Gemcitabine Versus Gemcitabine Monotherapy for Patients with Unresectable Metastatic Pancreatic Cancer in Japan;Value in Health Regional Issues;2022-03

5. Comparing jurisdiction-specific pharmaco-economic evaluations using medical purchasing power parities;Journal of Medical Economics;2021-11-16